SageView Advisory Group LLC Purchases 2,299 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

SageView Advisory Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 26.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 10,973 shares of the healthcare conglomerate’s stock after acquiring an additional 2,299 shares during the period. SageView Advisory Group LLC’s holdings in UnitedHealth Group were worth $5,526,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. BlackDiamond Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 31.7% in the fourth quarter. BlackDiamond Wealth Management LLC now owns 777 shares of the healthcare conglomerate’s stock valued at $391,000 after acquiring an additional 187 shares in the last quarter. WBI Investments LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $2,015,000. Annis Gardner Whiting Capital Advisors LLC boosted its position in UnitedHealth Group by 7.5% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 986 shares of the healthcare conglomerate’s stock valued at $519,000 after buying an additional 69 shares during the last quarter. Frazier Financial Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $353,000. Finally, Tidemark LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $347,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Truist Financial reaffirmed a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. TD Cowen lowered their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Finally, Royal Bank of Canada cut their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Trading Down 0.9 %

UNH stock traded down $4.52 during trading on Thursday, reaching $516.83. 2,859,935 shares of the stock traded hands, compared to its average volume of 4,176,011. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The business’s 50 day moving average price is $488.32 and its 200-day moving average price is $511.06. The firm has a market capitalization of $475.69 billion, a PE ratio of 31.64, a P/E/G ratio of 1.52 and a beta of 0.55. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the prior year, the firm earned $6.26 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.